{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "19",
          "submission_status": "AP",
          "submission_status_date": "20150501",
          "submission_public_notes": "Please see <a href=\"https://www.fda.gov/STIC/\">www.fda.gov/STIC</a> for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "39322",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050780s019lbl.pdf",
              "date": "20150504",
              "type": "Label"
            },
            {
              "id": "30528",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/050780Orig1s019ltr.pdf",
              "date": "20150504",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20070910",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "8273",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/050780s011ltr.pdf",
              "date": "20070911",
              "type": "Letter"
            },
            {
              "id": "18233",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050780s011lbl.pdf",
              "date": "20070911",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20030818",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "8272",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/50780slr005ltr.pdf",
              "date": "20030829",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20010221",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "42733",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/50780_Cefuroxime.html",
              "date": "20010221",
              "type": "Review"
            },
            {
              "id": "8271",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/50780_Cefuroxime_approv.pdf",
              "date": "20010221",
              "type": "Letter"
            },
            {
              "id": "18232",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/50780_Cefuroxime_prntlbl.pdf",
              "date": "20010221",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "18",
          "submission_status": "AP",
          "submission_status_date": "20131212",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "20",
          "submission_status": "AP",
          "submission_status_date": "20201205",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "65523",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/050780Orig1s020ltr.pdf",
              "date": "20201208",
              "type": "Letter"
            },
            {
              "id": "65550",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050780s020lbl.pdf",
              "date": "20201209",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20050506",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "30527",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/050780s008ltr.pdf",
              "date": "20050517",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20040629",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "30526",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50780slr006ltr.pdf",
              "date": "20040701",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA050780",
      "sponsor_name": "B BRAUN",
      "openfda": {
        "application_number": [
          "NDA050780"
        ],
        "brand_name": [
          "CEFUROXIME AND DEXTROSE"
        ],
        "generic_name": [
          "CEFUROXIME AND DEXTROSE"
        ],
        "manufacturer_name": [
          "B. Braun Medical Inc."
        ],
        "product_ndc": [
          "0264-3112",
          "0264-3114"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "CEFUROXIME SODIUM"
        ],
        "rxcui": [
          "1665444",
          "1665449"
        ],
        "spl_id": [
          "6874a295-7ec7-4822-9d04-4dd9932b4546"
        ],
        "spl_set_id": [
          "07170ee3-1a24-424f-a2a2-00bc92e98f85"
        ],
        "package_ndc": [
          "0264-3112-11",
          "0264-3114-11"
        ],
        "unii": [
          "R8A7M9MY61"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER",
          "active_ingredients": [
            {
              "name": "CEFUROXIME SODIUM",
              "strength": "EQ 1.5GM BASE/VIAL"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Discontinued",
          "te_code": "AP"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER",
          "active_ingredients": [
            {
              "name": "CEFUROXIME SODIUM",
              "strength": "EQ 750MG BASE/VIAL"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Discontinued",
          "te_code": "AP"
        }
      ]
    }
  ]
}